Project Grant R35GM158201

Award Date 7/1/25
Completion Date 6/30/30
Dollars Obligated $342K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $290,986 Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) to Chembind LLC, located in Atlanta, GA. The grant will fund the synthesis of 38 unique sulfated O-GalNAc glycans using a Sulfated Modular Synthesis/Enzymatic Assembly (SMSEA) approach. This comprehensive library of well-defined sulfated glycans will serve as an invaluable toolkit to advance the understanding of their biological...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), will support research to develop a small molecule-based platform to map the reader proteins of glycosylation. The five-year project, awarded in the amount of $390,000.00 effective February 1, 2025, aims to decipher the protein-carbohydrate interaction code, particularly for disease-related interactions, which could enable the...
This federal Project Grant award, R35GM156609, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859). The $382,500 award, effective January 1, 2025 through December 31, 2029, supports research to investigate how the spatial organization of glycan ligands on cell membranes influences glycobiology processes. The project aims to develop analytical approaches that can directly monitor dynamic glycan...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) will support research on how N-glycosylation regulates the function and activity of the endoplasmic reticulum chaperone protein GRP94. The $388,000 award to the Hauptman Woodward Medical Research Institute in Buffalo, NY, will run from September 1, 2024 to August 31, 2028. The research aims to determine how differential glycosylation...
The National Institute of General Medical Sciences (NIGMS) awarded a 5-year, $471,019 Project Grant (CFDA 93.859 - Biomedical Research and Research Training) to Georgia Tech Research Corp to conduct research on characterizing extracellular glycoproteins and unraveling their functions. The project aims to develop innovative mass spectrometry-based methods to comprehensively analyze glycoproteins on cell surfaces and in the secretome, as well as investigate the interactions between surface...
This $355,111 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research at the Pennington Biomedical Research Center to better understand the mechanisms and role of glycophagy, a process of glycogen degradation within lysosomes, and its contribution to cellular metabolism. The award will fund the development of novel genetically modified cells and mice, as well as innovative tools, to...
The National Institutes of Health National Institute of General Medical Sciences awarded a $903,000 Project Grant to The University of Toledo to develop new glycosylation methods for microbial glycan synthesis under the Biomedical Research and Research Training program (CFDA 93.859). Over a three-year period from September 2022 to August 2025, the University will create two new catalytic glycosylation methodologies - a cationic gold(I)-catalyzed glycosylation using glycosyl...
This federal Project Grant award of $445,000.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research to advance the understanding of G protein-coupled receptors (GPCRs) and trimeric G proteins. The key products and services to be delivered under this 5-year award include: Dissecting the structural basis of allosteric modulation by the third intracellular loop (ICL3) of GPCRs and defining its roles in...
This $439,992 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) supports the development of efficient synthetic mimics of enzymes and antibodies for targeting complex biological molecules such as glycans, peptides, and post-translationally modified proteins. The principal investigator's research group at Iowa State University aims to create water-soluble, protein-sized, molecularly...
This federal Project Grant award of $597,573.00 was issued by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports advanced structural and dynamic studies of large protein and protein-nucleic acid complexes and assemblies that play key roles in human health and disease. The research aims to provide atomic-level insights into the structure, dynamics, interactions, and function of chromatin...

This federal Project Grant award of $342,342 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports a research program focused on "Chemistry-Enabled Glycoscience". The project aims to develop and apply novel chemical tools and approaches to study the role of glycosylation in human diseases, such as cancer and Alzheimer's disease. Key efforts include generating cell/tissue-selective reporters and inhibitors of glycosylation, creating activity-based probes of monosaccharide biosynthesis, further understanding the effects of O-GlcNAc on protein aggregation, and investigating the consequences of mucin glycans on apolipoproteins. This 5-year grant, awarded to the University of Southern California, will advance the understanding of how changes in glycosylation impact the biochemistry and function of critical proteins involved in various human health conditions.

Generated 6/17/25, 2:13 AM